Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
|
|
ENZO BIOCHEM INC (ENZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/10/2023 |
SC 13D/A
| Radoff Bradley Louis reports a 9.3% stake in Enzo Biochem, Inc. |
| 01/23/2023 |
SC 13D/A
| Wolf James G. reports a 10.1% stake in ENZO BIOCHEM, INC. |
| 11/23/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/26/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/04/2022 |
SC 13D/A
| Radoff Bradley Louis reports a 8.9% stake in Enzo Biochem, Inc. |
| 12/27/2021 |
SC 13D/A
| Radoff Bradley Louis reports a 8.9% stake in Enzo Biochem, Inc. |
| 11/15/2021 |
SC 13D/A
| Wolf James G. reports a 6.7% stake in ENZO BIOCHEM, INC. |
| 10/28/2021 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 10.7% stake in Enzo Biochem, Inc. |
| 10/22/2021 |
SC 13D/A
| Radoff Bradley Louis reports a 7.5% stake in Enzo Biochem, Inc. |
| 09/30/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 6% stake in Enzo Biochem, Inc. |
| 05/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/17/2021 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 10.7% stake in Enzo Biochem, Inc. |
| 02/26/2021 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.7% stake in Enzo Biochem, Inc. |
| 01/15/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 01/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/04/2021 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.7% stake in Enzo Biochem, Inc. |
| 12/31/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/30/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.7% stake in Enzo Biochem, Inc. |
| 12/23/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/22/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/21/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/18/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/15/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.7% stake in Enzo Biochem, Inc. |
| 12/14/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/08/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/07/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/04/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 11/18/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.7% stake in Enzo Biochem, Inc. |
| 02/27/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.8% stake in Enzo Biochem, Inc. |
| 02/14/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.8% stake in Enzo Biochem, Inc. |
| 02/07/2020 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.8% stake in Enzo Biochem, Inc. |
| 09/17/2019 |
SC 13D/A
| Harbert Discovery Fund, LP reports a 11.8% stake in Enzo Biochem, Inc. |
| 07/25/2019 |
SC 13D/A
| Roumell Asset Management, LLC reports a 0% stake in Enzo Biochem Inc. |
|
|
|